
pmid: 18467582
A quarter century of scientific discovery has been applied to developing an AIDS vaccine, yet this goal remains elusive. Specific characteristics of the virus, including the extreme genetic variability in circulating viral isolates worldwide, biological properties of HIV that impede immune attack, and a high mutation rate that allows for rapid escape from adaptive immune responses, render this a huge challenge. However, evidence of protection against AIDS viruses in animal models and control of HIV in humans under certain circumstances, together with scientific advances in understanding disease pathogenesis, provide a strong rationale and objective paths to continue the pursuit of an effective AIDS vaccine to stem the global epidemic.
AIDS Vaccines, Acquired Immunodeficiency Syndrome, Clinical Trials as Topic, T-Lymphocytes, HIV Antibodies, History, 20th Century, History, 21st Century, Disease Models, Animal, Animals, Humans, T-Lymphocytes, Cytotoxic
AIDS Vaccines, Acquired Immunodeficiency Syndrome, Clinical Trials as Topic, T-Lymphocytes, HIV Antibodies, History, 20th Century, History, 21st Century, Disease Models, Animal, Animals, Humans, T-Lymphocytes, Cytotoxic
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 302 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 0.1% |
